rs148412639
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PVS1_ModeratePP5BS1_Supporting
The NM_000379.4(XDH):c.1686+1G>C variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000925 in 1,613,748 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000379.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XDH | NM_000379.4 | c.1686+1G>C | splice_donor_variant, intron_variant | Intron 16 of 35 | ENST00000379416.4 | NP_000370.2 | ||
XDH | XM_011533095.3 | c.1683+1G>C | splice_donor_variant, intron_variant | Intron 16 of 35 | XP_011531397.1 | |||
XDH | XM_011533096.3 | c.1686+1G>C | splice_donor_variant, intron_variant | Intron 16 of 28 | XP_011531398.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 87AN: 152166Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000466 AC: 117AN: 251112Hom.: 1 AF XY: 0.000472 AC XY: 64AN XY: 135706
GnomAD4 exome AF: 0.000962 AC: 1406AN: 1461464Hom.: 1 Cov.: 31 AF XY: 0.000901 AC XY: 655AN XY: 727036
GnomAD4 genome AF: 0.000571 AC: 87AN: 152284Hom.: 1 Cov.: 32 AF XY: 0.000578 AC XY: 43AN XY: 74448
ClinVar
Submissions by phenotype
Hereditary xanthinuria type 1 Pathogenic:2Uncertain:1
The c.1686+1G>C (NM_000379.3 c.1686+1G>C) variant in XDH has not been reported i n individuals with xanthinuria. This variant has been identified in 0.076% (50/6 5,368) of European chromosomes by the Exome Aggregation Consortium (ExAC, http:/ /exac.broadinstitute.org; dbSNP rs148412639). Although this variant has been see n in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant occurs in the invariant region (+/- 1 /2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. Biallelic loss of function of the XDH gene has been associated with xanthinuria type I. In summary, although additiona l studies are required to fully establish its null effect, the c.1686+1G>C varia nt is likely pathogenic for xanthinuria, type I based upon its predicted functio nal impact. -
- -
- -
XDH-related disorder Pathogenic:1
The XDH c.1686+1G>C variant is predicted to disrupt the GT donor site and interfere with normal splicing. To our knowledge, this variant has not been reported in affected individuals, but has been reported as likely pathogenic in a carrier screening study of newborns (Table S2, Ceyhan-Birsoy et al. 2019. PubMed ID: 30609409). This variant is reported in 0.091% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Variants that disrupt the consensus splice donor site in XDH are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Xanthinuria type II Pathogenic:1
This sequence change affects a donor splice site in intron 16 of the XDH gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in XDH are known to be pathogenic (PMID: 9153281). This variant is present in population databases (rs148412639, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with XDH-related conditions. ClinVar contains an entry for this variant (Variation ID: 505602). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not provided Uncertain:1
Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown; Has not been previously published as pathogenic or benign in association with xanthinuria to our knowledge; This variant is associated with the following publications: (PMID: 31589614, 30609409, 31980526, 31345219) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at